Eric J. Ende, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 30,000 shares at $7.84 ($235K) on 2025-01-13, disclosed to the SEC on 2025-01-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AVDL | BUY | 2022-06-01 | $78K | — | Filing → |
| AVDL | BUY | 2022-05-31 | $37K | — | Filing → |
| AVDL | BUY | 2020-09-18 | $98K | — | Filing → |